Eligard 7.5 mg

Eligard 7.5 mg is a sustained-release leuprolide acetate powder for subcutaneous injection. It is commonly used for hormone-related conditions, including prostate cancer. This long-acting formulation is designed for convenient administration.

Eligard 7.5 mg is primarily used for the management of advanced prostate cancer. Leuprolide acetate, the active ingredient, works by reducing the production of certain hormones. This medication is often prescribed as part of a broader treatment plan for hormone-sensitive conditions.

Common effects of Eligard 7.5 mg may include temporary discomfort at the injection site, hot flashes, and fatigue. Some users may experience changes in mood or energy levels. These effects vary and are not exhaustive; individual experiences may differ.

Eligard 7.5 mg should be handled with care, as it is a sustained-release formulation. It is important to follow the prescribed administration guidelines and store the medication properly. Always consult a healthcare provider before starting or stopping any medication.

Leuprolide acetate may interact with other medications, including those that affect hormone levels. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain supplements may also interact with this medication.